Creative Medical Technology Holdings Inc (CELZ)

[uvaphd]

Folks bought the hype in early-mid 2018. The company’s PRs were not “meaty” enough (as I said THEN) to sustain the PPS. Now, 2 years later and approaching 1.5 years since the CaverStem trial ended on 8/28/18, we are no closer not clarity on so many business fundamentals that sustain the value proposition and shareholder equity for ANY business—in fact, the silence and lack of explicit follow-up have gotten markedly WORSE...